Summary and Videos Roundtable ET 1
The Essential Thrombocythemia (ET) Roundtable 1, organized by the Global MPN Scientific Foundation, provided a unique space for patients to share their experiences, discuss challenges, and connect with others facing similar realities. The discussions covered various aspects of living with ET, from the moment of diagnosis to long-term treatment effects and the emotional toll of the disease.
Part 1 – Laura: A Patient Living with ET
Laura shared how her diagnosis was unexpected, discovered during a routine blood donation. Initially asymptomatic, she later faced treatment side effects before stabilizing with interferon therapy, which also allowed her to have a child. Another participant recalled being misdiagnosed with leukemia, leading to years of emotional distress before finally accepting and managing her condition.
Part 1: https://vimeo.com/1060564562/31ff678ff1?share=copy
Part 2 – The Challenges of Treatment
One participant detailed her struggles with multiple medications, starting with anagrelide, then hydroxyurea, and later interferon. Each treatment presented new challenges, from debilitating side effects to mental health issues. The discussion highlighted the need for more personalized treatment options and better patient support.
Part 2: https://vimeo.com/1060564652/0b6ac5b3f2?share=copy
Part 3 – Marcos: ET and Sports
Despite his ET diagnosis, Marcos maintains an active lifestyle, participating in running and cycling. He shared how mental resilience and self-care have helped him continue his passions while managing occasional fatigue and itching. The conversation emphasized how ET affects individuals differently and the importance of staying physically activewhen possible.
Part 3: https://vimeo.com/1060564761/16debf4f08?share=copy
Part 4 – Rosa: A Complex Diagnosis
Rosa described her long and difficult diagnostic journey, initially dismissed by doctors until she insisted on further testing. She started treatment with aspirin (Adiro), then hydroxyurea, experiencing severe side effects. When offered the opportunity to join a clinical trial, she declined due to concerns about risks and uncertainty. Her story highlights the difficult choices ET patients face in balancing treatment effectiveness and quality of life.
Part 4: https://vimeo.com/1060564905/baa1c76038?share=copy
Part 5 – Melissa: Life with ET
Melissa recounted how her ET symptoms, such as severe headaches and blurred vision, led to her diagnosis. She struggled to access specialists in the public health system, leading to delays in treatment. Now, she focuses on self-education and staying informed about new therapies, particularly her interest in Besremi as a potential treatment option.
Part 5: https://vimeo.com/1060564988/26e97c4a88?share=copy
Part 6 – Final Thoughts
The roundtable concluded with a discussion on the need for better communication between patients and healthcare providers, as many feel that doctors prioritize lab results over their overall well-being and quality of life. Participants emphasized the importance of patient advocacy and raising awareness with regulatory agencies to improve treatment options. The conversation ended with a call for unity, encouraging patients to organize as a community to drive change.